MENU

ALLO Allogene Therapeutics Forecast, Technical & Fundamental Analysis

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases... Show more

Industry: #Biotechnology
ALLO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ALLO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALLO is expected to report earnings to rise 12.54% to -14 cents per share on October 29

Allogene Therapeutics ALLO Stock Earnings Reports
Q3'26
Est.
$-0.15
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.01
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.03
The last earnings report on August 12 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 3.01M shares outstanding, the current market capitalization sits at 563.15M.
A.I. Advisor
published General Information

General Information

a developer of allogeneic chimeric antigen receptor therapy

Industry Biotechnology

Industry
Biotechnology
Address
210 East Grand Avenue
Phone
+1 650 457-2700
Employees
152
Web
https://www.allogene.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSM2.211.09
+97.32%
Sono Group NV
PAYO7.14N/A
N/A
Payoneer Global
OWLS5.43N/A
-0.09%
OBOOK Holdings Inc.
NTIC7.71-0.07
-0.90%
Northern Technologies International Corp
AEG8.49-0.14
-1.62%
Aegon Ltd

ALLO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with EDIT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
-3.75%
EDIT - ALLO
47%
Loosely correlated
-1.95%
AXON - ALLO
44%
Loosely correlated
-0.07%
ARRY - ALLO
43%
Loosely correlated
-3.47%
VYGR - ALLO
43%
Loosely correlated
-0.19%
RCKT - ALLO
43%
Loosely correlated
-1.52%
More
Allogene Therapeutics (ALLO) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com